Answers are grounded in this paper and cite their sources.
Variations in AED prescribing during pregnancy indicate the potential for further reductions, particularly of valproate. Increases in pregabalin/gabapentin prescribing, for which risks are not well known, are a cause for concern.
No takes yet. Share an insight, caveat, or question.
Hurault‐Delarue et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: